Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Unravel Biosciences
Unravel Biosciences uses patient RNA data and AI to rapidly identify and validate drug targets for complex and rare disorders in plain terms. The company combines a proprietary foundation model of…
Unravel Biosciences
Unravel Biosciences uses patient RNA data and AI to rapidly identify and validate drug targets for complex and rare disorders in plain terms. The company combines a proprietary foundation model of…
TL;DR
Stage: Clinical-stage therapeutics developer
Core tech: Patient RNA + AI-driven systems-biology (BioNAV™, Living Molecular Twins)
Focus: Drug repurposing and target discovery for rare and complex disorders
Founded: 2021
Recent funding: Grant announced Mar 29, 2023; total raised reported ~$3.28M
Company Overview
Problem Domain
Translating patient transcriptome signatures into actionable drug targets and repurposing opportunities for rare and complex disorders.
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
Recorded as a grant-led funding event
Investor Signal
“BoxOne Ventures; Creative Destruction Lab (CDL); Good Ventures; KdT Ventures; Massachusetts General Hospital; RTK Group”